2 September, 2021 by The TZ Newswire Staff Comments Off on Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
CUPERTINO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the H.C. Wainwright 23rd Annual Global Investment Conference as well as participate in one-on-one meetings with investors.
2 September, 2021 by The TZ Newswire Staff Comments Off on Duluth Holdings Inc. Announces Second Quarter 2021 Financial Results
Duluth Holdings Inc. Announces Second Quarter 2021 Financial Results
MOUNT HOREB, Wis., Sept. 02, 2021 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a growing lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel and accessories, today announced its financial results for the fiscal second quarter ended August 1, 2021.
2 September, 2021 by The TZ Newswire Staff Comments Off on Achilles Therapeutics to Present at Upcoming Investor Conferences
Achilles Therapeutics to Present at Upcoming Investor Conferences
LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that management will present at the following investor conferences in September.